Paul O’Connor

Statistics

Publications

Citations

1.3K

H-Index

Active since

2004

Affiliations

St. Michael's Hospital(Current)

University Hospital of Basel

Vita-Salute San Raffaele University

Rutgers New Jersey Medical School

Heinrich Heine University Düsseldorf

Paul O’Connor is an author at St. Michael's Hospital specializing in multiple sclerosis, neurology, and relapsing-remitting multiple sclerosis treatment.

Publications per year

2004–2015

Publications

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

Paul O’Connor, Massimo Filippi, Barry G.W. Arnason et al. · The Lancet Neurology · 2009 · 403 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +8

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial

Patrick Vermersch, Anna Członkowska, Luigi ME Grimaldi et al. · Multiple Sclerosis Journal · 2013 · 351 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +16

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

V. Devonshire, Eva Havrdová, Ernst W. Radue et al. · The Lancet Neurology · 2012 · 182 citations

Medicine, Neurology, Disability Management +12

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

Kathryn C. Fitzgerald, Kassandra L. Munger, Karl Köchert et al. · JAMA Neurology · 2015 · 169 citations

Medicine, Neurology, Pharmacotherapy +17

Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis

Catherine M. Dalton, Katherine Miszkiel, Gareth J. Barker et al. · Journal of Neurology · 2004 · 126 citations

Life Sciences, Neurology, Neuroscience +10

1–5 of 10